Earnings4967KOBAYASHI PHARMACEUTICAL CO.,LTD.
Kobayashi Pharmaceutical Reports Q2 Revenue of 70.7 billion, Up 2%
TOKYO, Aug 06 (Pulse News Wire) – Kobayashi Pharmaceutical Co., Ltd. (4967.T) reported consolidated results for Q2 FY2026 (ending December 2026).
Revenue was ¥70.7 billion (+2.5% YoY). operating profit was ¥2,162 million (-67.5%). net profit attributable to shareholders was ¥1,136 million (-64.1%).
Total assets stood at ¥250 billion with an equity ratio of 82.9%. The company declared an annual dividend of ¥61 per share. The full-year forecast for the current fiscal year is revenue of ¥170 billion (+4.4%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥70,749M | +2.5% |
| Operating profit | ¥2,162M | -67.5% |
| Net profit | ¥1,136M | -64.1% |
Next period forecast
Revenue
¥173,000M
+4.4%Op. profit
¥12,500M
-16.2%Net profit
¥10,000M
+173.5%Figures in millions of yen
End of article